Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial. Επικοινωνία Submitted by Εμμανουήλ Ροηλίδης on Παρ, 11/13/2020 - 09:19
